1997
DOI: 10.1016/s0002-9378(97)70454-x
|View full text |Cite
|
Sign up to set email alerts
|

Maternal characteristics and risk of severe neonatal thrombocytopenia and intracranial hemorrhage in pregnancies complicated by autoimmune thrombocytopenia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

4
73
1
16

Year Published

1999
1999
2017
2017

Publication Types

Select...
5
3
1

Relationship

0
9

Authors

Journals

citations
Cited by 135 publications
(94 citation statements)
references
References 21 publications
4
73
1
16
Order By: Relevance
“…Additionally, searching for reliable predictors of NITP, we conducted a review of a total of 22 reported cases of fetal or neonatal ICH with NITP secondary to maternal ITP published from 1960 to 2010 [4,[6][7][8][9][10][11][12][13][14][15][16][17][18][19][20][21][22]. The result was summarized in Table IV.…”
Section: Resultsmentioning
confidence: 99%
“…Additionally, searching for reliable predictors of NITP, we conducted a review of a total of 22 reported cases of fetal or neonatal ICH with NITP secondary to maternal ITP published from 1960 to 2010 [4,[6][7][8][9][10][11][12][13][14][15][16][17][18][19][20][21][22]. The result was summarized in Table IV.…”
Section: Resultsmentioning
confidence: 99%
“…Gernsheimer et al [21], recommend the use of corticosteroids or IVIG if platelet count falls below 20--30 × 10 9 /L. Some studies consider the following as important predictors of an increased risk of neonatal thrombocytopenia: maternal history of splenectomy, maternal platelet count of < 50 × 10 9 /L at some point during the pregnancy, and a previous pregnancy complicated with neonatal thrombocytopenia [23][24][25][26]. Noris et al [27], performed a multicenter, retrospective study evaluating 339 pregnancies in 181 women.…”
Section: Discussionmentioning
confidence: 99%
“…17,18 However, more recent data do not support a correlation between fetal scalp platelet count and neonatal platelet count at birth and they provide evidence that percutaneous umbilical vein sampling is associated with a high incidence of complications. 19 Furthermore, the universal application of CS delivery to pregnant patients with immune-mediated thrombocytopenia has not been shown to decrease the incidence of intraventricular hemorrhage. 20 A review of 601 infants born to women with immune thrombocytopenia showed that severe neonatal thrombocytopenia was present in 72/601 (12%) and that the neonatal intracranial hemorrhage is extremely rare and unrelated to the mode of delivery.…”
Section: Gestational Vs Sle-associated Thrombocytopeniamentioning
confidence: 99%